Search Results Matching Geography
| Region: | |
| Category: |
|
Kuwait Pharmaceuticals and Healthcare Report Q2 2012
3/20/2012 | published by: Business Monitor International
... increasingly challenging operating environment across the GulfCooperation Council (GCC) as a whole. We still expect Kuwait’s pharmaceutical market to growsteadily, driven by epidemiological and demographic changes, as well as healthcare system reform, butthe distributors of ...
|
more...
|
$1,175.00
|
|
Israel Pharmaceuticals and Healthcare Report Q2 2012
3/20/2012 | published by: Business Monitor International
... has been able to support it by subsidising sick funds tomake a wider range of treatments available. In particular the introduction of some expensive biologicaldrugs into the re-imbursement basket will present opportunities for multinational drugmakers. ...
|
more...
|
$1,175.00
|
|
Lebanon Pharmaceuticals and Healthcare Report Q2 2012
3/20/2012 | published by: Business Monitor International
... multinationaldrugmakers via a reduction in the number of counterfeit and substandard drugs and the enlargement ofthe legitimate pharmaceutical market. However, we highlight Lebanon's close ties with Syria as a risk.Instability in the region, combined with ...
|
more...
|
$1,175.00
|
|
Oman Pharmaceuticals and Healthcare Report Q2 2012
3/6/2012 | published by: Business Monitor International
... has also increased the allocation for social security and welfare by 74% y-o-y to OMR385mn (US$1.01bn). Expenditure on the health sector is an estimated OMR500mn (US$1.32bn), which is five percent of total public expenditure. Furthermore, ...
|
more...
|
$1,175.00
|
|
Qatar Pharmaceuticals and Healthcare Report Q2 2012
3/6/2012 | published by: Business Monitor International
... years. Having said this, strong demand for high-value medicines and a favourable risk profile will remain attractions for drugmakers. Headline Expenditure Projections Pharmaceuticals: QAR1.42bn (US$390mn) in 2011 to QAR1.55bn (US$426mn) in 2012; +9.2% in local ...
|
more...
|
$1,175.00
|
|
Israel Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others
2/29/2012 | published by: GlobalData
... Management, Wound Closure Devices, Pressure Relief Devices and Others” provides key market data on the Israel Wound Care Management market. The report provides value (USD million), volume (units) and average price (USD) data for each ...
|
more...
|
$2,500.00
|
|
The Outlook for Pharmaceuticals in the Middle East and North Africa (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... five MENA markets covered in this collection will represent a combined GDP of US$2.5 trillion in 2016, led by Turkey and Saudi Arabia. Economic development is changing the epidemiological health profile in the region, with ...
|
more...
|
$3,630.00
|
|
The 2009 Import and Export Market for Chromatographs and Electrophoresis Instruments in the Middle East
5/16/2009 | published by: Icon Group International, Inc.
... dollar value of these imports? How much do the imports of chromatographs and electrophoresis instruments vary from one country to another in the Middle East? Do exporters serving the market in the Middle East have ...
|
more...
|
$325.00
|
|
A Quick Guide to Healthcare and Biotechnology in the Middle East
4/1/2009 | published by: BioPlan Associates, Inc.
... explore how healthcare is developing in this important world region and what this means for the pharmaceutical and biotech sectors. Most major companies have some presence in the Middle East but in the past have ...
|
more...
|
$148.00
|
|
Major Pharmaceutical Markets of the Middle East
2/14/2009 | published by: Urch Publishing
... to become self-sufficient in pharmaceuticals production.” Major Pharmaceutical Markets of the Middle East (2nd Edition) is a comprehensive report providing extensive coverage of one of the strongest emerging markets. Through quality analysis and forecasts, this ...
|
more...
|
$2,030.00
|
|
Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.)
11/1/2007 | published by: Kalorama Information
... problems. This provides an opportunity for BRIC countries and other developing regions to grab a piece of the clinical trial market. Countries such as India and China have a vast population who are interested in ...
|
more...
|
$1,500.00
|
